← Back to all signals
RESEARCH PAPER ANALYSIS

Interventions to Reduce Pediatric Cancer Treatment Abandonment in Low- and Middle-Income Countries: A Scoping Review.

AI interpretation is pending for this paper.

Open original publication →
PMID40950429
JournalmedRxiv : the preprint server for health sciences
Publication Date2025-09-02
Ingested2026-08-02 12:05 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: Pediatric cancer treatment outcomes in low- and middle-income countries (LMICs) significantly lag behind those in high-income countries. One reason for this disparity is high treatment abandonment rates, defined as a failure to start or complete curative-intent therapy after a cancer diagnosis. We conducted a scoping review to describe interventions aimed at reducing treatment abandonment in pediatric cancer patients in LMICs. METHODS: Studies identified through systematic database search were included if they met the following criteria: (a) studied an intervention on treatment abandonment; (b) included cancer patients ≤18 years of age; (c) conducted in LMICs as defined by the World Bank income classification; (d) contained pre- and post-intervention measures of treatment abandonment. We restricted inclusion to English-language publications. Two reviewers independently screened the eligible publications and extracted the data. Interventions were categorized as focusing on socioeconomic support, education/psychosocial support, or clinical care quality and capacity improvements (e.g., care navigation, coordination, or therapeutic/diagnostic expansion). FINDINGS: Among the 1,808 articles identified in the search, 21 studies met inclusion criteria: four from the WHO African region, nine from the Americas, seven from the South-East Asian, and three from the Western Pacific Region. Sixteen studies (66%) focused on one category for improvement, and eight (34%) were a mixture of two or more categories. All studies demonstrated a decrease in treatment abandonment after the intervention. The median absolute risk reduction (ARR) was 16% (interquartile range [IQR] 10%-24%). The median relative risk reduction was 72% (IQR 60%-82%). The median pre-intervention abandonment rate across full-text studies was 27% (IQR 20%-34%) and decreased to 7% (IQR 3%-12%) after intervention. Interventions with the largest ARR values included components of socioeconomic support, psychosocial support, and clinic care improvements. All of the 10 studies reporting pre- and post-intervention survival outcomes reported increases in survival following the intervention. INTERPRETATION: Our scoping review describes interventions that were associated with reduced pediatric cancer treatment abandonment in LMICs. Interventions that combined socioeconomic support, psychosocial support, and clinical care quality/capacity improvements yielded the largest reductions. Despite these encouraging findings, limitations of the evidence, including short study durations, single-center designs, lack of control groups, and likely publication bias, restrict the generalizability of results. These findings suggest that treatment abandonment is a targetable and potentially modifiable challenge in LMICs, and that survival outcomes can improve when health systems adopt multifaceted interventions that support families and strengthen care delivery. FUNDING: National Institutes of Health, K12CA090433.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Clinical features and imaging diagnostic challenges of fetus-in-fetu associated with abdominal cryptorchidism: a case report. BMC pediatrics 49.0 2 [Exploring therapeutic mechanism of Compound Pien Tze Huang Tablets for adenoid hypertrophy in children based on network pharmacology and animal experiments]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 59.39 3 Actinomyces odontolyticus Infection of a Marsupialized Vallecular Cyst in a Two-Month-Old Infant: A Report of a Rare Case. Cureus 47.9 4 Further assessment of structural and social determinant of health effects on breast cancer care timelines: a qualitative study. Frontiers in oncology 61.9 5 Case Report: STAT3 hyper-IgE syndrome in children: two cases report with uncommon complications of tuberculosis and lymphoma. Frontiers in pediatrics 51.4 6 Case Report: Vincristine extravasation managed with amniotic membrane graft in a pediatric patient with Wilms tumor. Frontiers in pediatrics 54.7 7 Epigenetic regulation in medulloblastoma: from tumor heterogeneity to diagnostic, prognostic, and translational applications. Frontiers in molecular neuroscience 60.4 8 Fathers of Children With Cancer: Qualitative Insights and Nursing Implications. Oncology nursing forum 61.4 9 Financial Toxicity Among Family Caregivers of Pediatric, Adolescent, and Young Adult Patients With Cancer: A Qualitative Meta-Synthesis. Oncology nursing forum 60.62 10 Healthcare Access and Utilization in a National Sample of Cancer Survivors With a History of Military Service. Oncology nursing forum 64.0 11 Switching Between Anti-TNFs and Other Biologic Drugs in Paediatric Inflammatory Bowel Disease: A Narrative Review and Practical Clinical Guide. Journal of inflammation research 42.30 12 The clinical, functional and oncological outcomes of patients with giant cell tumour of bone. A long-term review. Journal of orthopaedic surgery (Hong Kong) 43.40 13 Body composition changes and nutritional challenges in children with acute lymphoblastic leukaemia: Perspectives from low-resource settings. The Indian journal of medical research 58.90 14 Clinical Relevance of Genomics Defined WHO5 Subtypes of Pediatric B-ALL in the Context of Measurable Residual Disease-Directed Risk-Based Therapy. JCO global oncology 63.00 15 Crossing Borders for Pathology Capacity Building in a Regional Setting: A Pediatric Oncology Initiative. JCO global oncology 57.5 16 Recognition and Management of Ulcerative Infantile Hemangioma: Risk Factors, Diagnosis, and Prognosis. Pediatric annals 62.8 17 Inborn Errors of Immunity and Hematopoietic Cell Transplantation: Recognition and Pretransplant Management. Pediatric annals 60.0 18 SLFN11 enhances cisplatin sensitivity in pediatric cancer via activation of stress-response and suppression of survival pathways. British journal of cancer 64.74 19 Phenotypic and genotypic characteristics of pediatric patients with neurofibromatosis type 1: a 12-year single-center cohort study. World journal of pediatrics : WJP 62.5 20 Supportive care needs among patients with breast and cervical cancer at a tertiary cancer treatment center in ethiopia: a cross-sectional study. Scientific reports 36.90 21 Laser interstitial thermal therapy in pediatric neurosurgery: a prospective nationwide study on indications, safety, and early outcomes. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 61.00 22 Pediatric T-cell lymphoblastic lymphoma with t(9;17)(q34;q23)-associated N-terminally truncated NOTCH1 activation: a case report. International journal of hematology 47.9 23 Inflammatory Myofibroblastic Tumor of the Central Airways: Case Report and Review of Diagnostic and Therapeutic Strategies. Case reports in pulmonology 51.14 24 Awareness level of cancer risk factors and warning signs among adults in Mansoura District, Egypt. BMC public health 61.0 25 A Three-Component Immune Framework Stratifies Treatment Response and Escalation in Pediatric Hemophagocytic Lymphohistiocytosis: A Prospective Single-Center Cohort Study. Pediatric blood & cancer 73.80 26 What a wonderful world: beyond relapsed pediatric acute myeloid leukemia. Haematologica 51.12 27 Real-world experience with IDH inhibitors in pediatric patients with IDH1- and IDH2-mutated acute myeloid leukemia and myelodysplastic syndrome. Haematologica 51.66 28 Pediatric-inspired therapy and blinatumomab consolidation improve outcomes in young adults with Philadelphia-like acute lymphoblastic leukemia. Haematologica 58.90 29 Assessment of testicular function in boys with hematological malignancies: a prospective longitudinal study. The Journal of clinical endocrinology and metabolism 65.2 30 Adverse health outcomes across the life course in individuals with six rare bone diseases: a 10-year population-based cohort study. European journal of endocrinology 57.5 31 Telemedicine in pediatric oncology during the COVID-19 pandemic: a cross-sectional questionnaire-based study evaluating the patient perspective. Pediatric hematology and oncology 65.1 32 Prevalence of hearing loss and tinnitus after childhood cancer treatment: a Danish nationwide registry-based study. Acta oto-laryngologica 40.80
PATIENT-FRIENDLY SUMMARY

Interventions to Reduce Pediatric Cancer Treatment Abandonment in Low- and Middle-Income Countries: A Scoping Review.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic